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Abstract. Current detection methods for Dementia and Alzheimer’s disease
include cerebral spinal fluid (CSF) markers and/or the use of positron emission
tomography (PET) imaging, both being high-cost, highly invasive testing
methods. The need for low-cost, minimally invasive methods to prescreen
individuals for cognitive impairment has been a challenge for many years.
Today’s costs associated with an annual screen for all adults 65 and above using
current methods (CSF, PET) reach well beyond trillions of dollars per year.
Motivated by the limited accessibly and high costs, an alternative tool presented
within this paper demonstrates an effective rule out screening for Dementia and
Alzheimer’s disease. Leveraging Electronic Health Records (EHR) data, lowcost computing, modern statistical modeling, and useable Machine Learning
algorithms were able to derive a screening tool that effectively detects 98 percent
of individuals without Dementia and Alzheimer’s disease. Approximately 43,000
EHR patient records’ totaling 5,000 patients from the University of North Texas
Health Science Center were evaluated using this new rule out screening method,
which consists of traditional Machine Learning models: Random Forest,
AdaBoost, SVM combined with the application of Natural Language Processing
of physician’s notes. The findings from this study help define a new paradigm in
medical practice where an effective rule out screening method for Dementia and
Alzheimer’s disease can be used as an initial screening tool. This study
effectively cuts the cost of current detection methods by 75 percent, gives access
to all adults age 65 and above while still leaving expensive methods as secondary
lines of detection.
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1

Introduction

For over 20 years, there has been the need for low-cost, minimally invasive Dementia
and Alzheimer’s disease screening methods for patients to better determine who does
not have the disease. By identifying those not at-risk from those at-risk within differing
healthcare environments, it is now possible to generate savings and better utilize current
high-cost testing methods (CSF/PET). A rule out approach greatly reduces the number
of patients escalated for higher cost neurodiagnostic testing. Rule out screening of
Dementia and Alzheimer’s disease gives patients peace of mind because the results
indicate the disease is not present. While at-risk patients are not diagnosed, they would
be referred on for additional neurodiagnostic testing; consistent with other screening
methods currently employed in other areas such as oncology.
Machine Learning models trained on EHR data using unstructured doctor’s notes
can provide a useful method for ruling out those without Dementia and Alzheimer’s
disease within a traditional clinic and hospital setting. Such an approach, to date, has
not been evaluated particularly with advanced statistical analytic methods (i.e. Machine
Learning). Despite the potential for the proposed applied Machine Learning solutions,
there are industry-wide hurdles regarding access to data that needs to be overcome
when using Electronic Health Records.
The Department of Health & Human Services (HHS) is committed to increasing
interoperability including the ability to exchange, interpret, and use medical data
cohesively, across all healthcare settings, servicers, and providers. As of 2015, 96
percent of hospitals and healthcare providers along with 78 percent of office-based
physicians use digital records [21]. The current disconnects in customer records is a
major issue. Neither patients nor doctors have consistent access to a patient’s entire
record history from varying institutions. Therefore, disconnections exist between the
different institutions, which means there not consistent data standards and or means. of
data collection. Unique EHR systems will require custom installation and setup of the
rule out tool within each environment.
A low-cost, highly accessible screening tool is presented here. EHR records can be
successfully utilized and quickly assembled into a functional resource that is used to
screen for Dementia and Alzheimer’s disease. The addition of Natural Language
Processing shows great promise as a new component to the screening tool, creating
untapped features that are highly important and produce better model predictions. The
findings discussed within add value to current medical and research literature by
demonstrating a screening tool that effectively detects individuals without Dementia
and Alzheimer’s disease for patients that visit their doctor.

2

Alzheimer’s disease

As an overview, Alzheimer’s disease is a neurodegenerative disease that is particularly
common in the senior population of 50 years and above. The disease was discovered in
1906 by Dr. Alois Alzheimer during an inspection of neural tissue from a deceased
elderly woman who had reported unusual mental illnesses. Some of her most notable
characteristics were memory loss, language difficulty, and erratic behavior. Physical
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characteristics of her brain included abnormal amyloid plaques and neurofibrillary
tangles which today are the hallmark characteristics synonymous with Alzheimer’s
disease [22].
2.1

Overview and Impact

As Alzheimer’s disease progresses in the brain, a buildup of amyloid plaques occurs
along with a noticeable destruction of neuronal connections reflecting
neurodegeneration. Typically, the hippocampal brain region (associated with memory)
is the first area to have noticeable damage followed by other areas of the brain. Once
Alzheimer’s disease has progressed to the state of being clinically detectable, there may
be damage throughout the brain along with a reduction in overall tissue volume [24].
The neurodegeneration occurs over time and eventually leads to a decline in cognitive
and functional abilities [16]. Alzheimer’s disease is known to begin years before
symptoms are detectable. The lack of detection allows degenerative biological states to
exist within individuals where disease pathologies can go undetected and unchecked
for several decades before symptom presentation, such as memory loss, are seen
[2],[3],[6],[11],[27].
The 2020 Alzheimer’s Association Report identifies the most common causes of
Dementia to be Alzheimer’s disease, Cerebrovascular Disease, Lewy Body Disease,
Frontotemporal lobar degeneration, Parkinson’s Disease, and Hippocampal sclerosis.
Mixed pathologies occur when an individual shows more than one cause of Dementia
[16]. This study highlights the fact and figures of Alzheimer’s disease due to the high
prevalence of disease; however, Alzheimer’s disease was not the only form of
Dementia within the data. Dementia, in general was used for analysis. Alzheimer’s
disease is the most notable and prevalent form of Dementia and contributes to around
60 to 70 percent of all Dementia cases. The term Dementia describes the neurocognitive
and functional decline of patients and is the overarching terminology used to
characterize symptoms of memory loss along with changes in thinking, language skills,
and problem solving. This study utilizes Alzheimer’s disease as an additional outcome
due to the high prevalence of the disease; however, Alzheimer’s disease was not
specifically identified within the data. Dementia, in general was therefore used for
analysis as the primary outcome variable.
Most concerning is the seriousness of the damage caused by Alzheimer’s disease
and the staggering occurrence rates. As of 2017, experts have estimated 5.5 million
Americans have Alzheimer’s disease, and the disease is not just limited to the senior
community. The incident rates of Alzheimer’s disease continue to increase as the global
population grows and continues to age [22]. To put these large numbers into
perspective, 1 in 10 people age 65 and above experiences Alzheimer’s disease or some
form of Dementia [9]. The prevalence (existing cases) of Alzheimer’s disease also
increases with age; ranging around 3% of people aged 65−74 to 32% of people age 85
and above [9]. Patient lifespan post diagnosis may range from 3−10 years, Alzheimer’s
disease is estimated as the sixth leading cause of death in the United States and possibly
the third leading cause for the older community. The only other causes of death that
ranked higher for the elderly population was heart disease and cancer [22].
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It is estimated that more than 16 million unpaid caregivers provide care for
individuals with Alzheimer’s disease and Dementia. These unpaid caregivers provided
an estimated 18.6 billion hours of unpaid care, valued at $244 billion dollars in
contributions in 2016 [16]. Caring for a person with Alzheimer’s disease has special
challenges and levels of care will likely increase with the progression of the disease.
As the disease worsens, more serious health problems usually arise. Incomes and
finances regularly become depleted causing high levels of emotional stress and
depression for many of these caregivers [16]. Direct care (paid) workers, usually
nursing assistants, consistently have a difficult job due to a lack of training and
education required for Alzheimer’s disease and Dementia care.
Making matters worse, as of 2016, there is a shortage of certified geriatricians with
only 7,293 in the United States. That is one geriatrician for every 1,924 Americans age
65 or older in need of care [16]. The American Geriatrics Society estimates that by
2030 an additional 23,750 geriatricians are needed to meet the aging population [16].
In 2017, Medicare started reimbursing healthcare professionals for comprehensive
Dementia health care plans for care visits to help address short comings in healthcare
planning. Medicare stated prehensive care planning is a core element of effective
Dementia care management and can result in the delivery of services that potentially
enhance quality of life for people with Dementia and their caregivers [16].
The economic impact and cost have enormous implications for individuals and their
families affected by Alzheimer’s disease. Lifetime costs for care of a single individual
were estimated at $357,297 in 2019 [14]. Alzheimer’s disease and Dementia have
become the costliest condition, with over $290 billion made in payments 2020 for
health and long−term care [10]. Considering the population of individuals currently
with Alzheimer’s disease today (5.8 million) and the number of individuals forecasted
in future (88 million affected by 2050), the estimated cost is projected to reach $4.6
trillion. The estimated number of future cases, high costs of care and ageing population
push the importance of an early diagnostic test to a real priory for public healthcare.

Figure 1: Aggregated costs of healthcare payments made by Americans age 65 and
older with Alzheimer’s disease or dementia in 2020. Reported in the Alzheimer's
Association Report and data displayed from the Lewin Model [22].
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Despite the dire consequences of developing Dementia or Alzheimer’s disease, there
is currently no cure, and there is still much to learn about the disease itself. There are
currently only 5 FDA approved medications, none of which has shown supportable
evidence for the permanent reduction/remission of Alzheimer’s disease symptoms.
Rather, the only limited achievements of these medications are to manage and slow the
symptoms of neurocognitive degradation characterized by Alzheimer’s disease and
Dementia. To say medication development has been slow would be an understatement,
as there are no medications that prevent or delay the progression of the disease. The
most recently FDA approved Alzheimer’s disease medication is simply a cocktail of
two other Alzheimer’s disease drugs from 23 and 16 years ago. There are efforts to
develop new medications. However, clinical trials have seen a staggering 99.6% failure
rate.
Many research documents cite major challenges in that there is still not much known
about the cause of Alzheimer’s disease and that finding Alzheimer’s disease patients at
early development stages is crucial. It has been estimated that potentially half of
patients with Alzheimer’s disease are undiagnosed or experience anosognosia (inability
to recognize they have memory changes) [16],[11]. Not having access to effective
screening solutions perpetuates missed diagnoses. A rule out screening method that can
effectively identify most of the population without the presence of Alzheimer’s disease
or Dementia allows the focus to shift towards those at-risk patients. Finding suitable
clinical trial participants has been difficult and has high costs associated with it.
Without a suitable pool of subjects, it becomes extremely difficult to carry out research
on Dementia and Alzheimer’s disease. The rule out screening method is a novel way to
overcome some clinical trial hurdles by lowering the cost of inclusion and exclusion
criteria for trials ensuring the focus and expense is used on individuals who can help
drive development of potential lifesaving measures, treatments, and medications [1].
2.2

Detection Approaches and Related Works

The gold standard screening methods used to identify Dementia and Alzheimer’s
disease are Positron Emission Tomography (PET) and CSF marker analysis, each have
their own respective tradeoffs. To date, there have not been any predictive models
approved by the FDA, which creates a gap in screening. Gold standard methods are
expensive and may not be covered all by insurance providers. In recent years, research
advancements of noninvasive screening methods have been developed utilizing
predictive analytics.
The major advantage in utilizing Machine Learning methods is that screening can
be done on larger populations and at-risk individuals can be identified in a low-cost,
noninvasive manner. Therefore, using predictive analytics to identify undiagnosed
Alzheimer’s disease and Dementia can provide real value to the realm of research and
treatment by way of earlier diagnosis. Although the field of predictive analytics has
been around for quite some time, recent advancements in computing capabilities and
research in the field have led to much more widespread adoption in the industry.
Predictive Analytics and coined terms such as “Machine Learning” and “artificial
intelligence,” consists of preparing, cleaning, and processing suitable training data in
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order to train a series of predictive mathematical models. From there, the models will
typically “learn” by calculating a loss function to measure the total accuracy (or other
chosen performance metric) of the model and then back propagation seeks to adjust
model weights in order minimize aforenoted loss function.
Several groups have demonstrated success using Machine Learning and predictive
analytics. McCoy et al (2018, 2019) aimed to help prevent Dementia by identifying
pre-symptomatic and/or individuals with minimal symptoms that were at high-risk for
Dementia. McCoy and colleagues identified that traditional current detection of
Alzheimer’s disease and Dementia are expensive, and that reliability and scalability are
not consistent. McCoy subsequently proposed that an Electronic Health Record (EHR)
method of screening could be a potential solution for early detection [18]. In their work,
Natural Language Processing (NLP) was used on free text from hospital discharge notes
where a "Cognition Score" was generated and compared with other medical records.
These discharge notes capture key indicators of Alzheimer’s disease that may not be
captured by ICD−10 codes. ICD-10 codes are a standardized set of codes that classify
and document disease diagnoses. For analysis, each study site data was merged to form
a holistic view [17]. Association between model score and Alzheimer’s disease related
death rates were then studied to better understand the progression of Alzheimer’s
disease. The McCoy paper further states additional validation is needed to show the
effectiveness of the NLP approach and the need for future iterations of the model to
incorporate other biomarkers and medical records. From McCoy’s work, a lexicon
containing Alzheimer’s disease and Dementia key words and stop words has been made
available. Incorporating the limitations mentioned by McCoy, use of additional fields
and NLP analysis may build a more robust and predictive model.
The Scripps Research Translational Institute utilized over 1 million patient medical
records representing 11 years of data. The incidence of Alzheimer’s disease was low in
the study population. To allow the models to better classify the low volume of
Alzheimer’s records, the data was balanced using bootstrap sampling. Random Forest,
Support Vector Machine, and Logistic Regression were utilized on 5 groups of data
with time points zero, one, two, three, and four subsequent years incidence of
Alzheimer’s disease. Within each group the models classified Alzheimer’s records with
the following operational definitions: definite Alzheimer’s disease and probable
Alzheimer’s disease based on patient medical records. The top 20 features were
selected using Logistic Regression, then used in other models for comparison. Several
key features that were identified were elevated urine protein, Zotepine, and several
ICD-10 codes. These features were deemed statistically significant and produced high
odds ratios for Alzheimer’s disease suggesting that these features were more strongly
associated with incidence of disease.
The Scripps group showed Random Forest models had the highest accuracies for
most of the subsequent years of incidence for definite and probable Alzheimer’s
disease. Predictions are acceptable for 0−and 1−year incidence with an AUC of 0.898
and 0.775 respectively [18]. However, as time increases to 4 years the model
performance starts to decrease. This trend was consistent across all models for
prediction of definite or probable Alzheimer’s disease. This research does not mention
the use of any free form text field or the use of Natural Language Processing techniques
to model this data. Relevant information captured from a doctor’s observations could
provide key indications for Alzheimer’s disease incidence.
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Another interesting point presented by the Park et al paper described feature
selection using a Logistic Regression approach for comparison with other models.
Several key risk factors were identified and have shown to contribute to Alzheimer’s
through their high odds ratios; this can be used as a potential starting point for our
group’s models [23].
The papers from the Center for Quantitative Health at Massachusetts General
Hospital, Harvard, and Scripps Research Translational Institute both suggest that
document classification can be used to improve the efficiency and increase robustness
of predictive models. The paper by Peng et al shows how document classification
accuracy can be improved over traditional "bag−of−words" using Natural Language
Processing techniques to extract word senses and from the context of the entire
document. This approach provides a potential 14% increase in accuracy over
bag−of−words techniques [24]. Peng suggests a shift in modeling from word
frequencies to sense frequencies. Senses rely on the meaning of words and the
relationships between groups of meanings [24].
Shifting from a lexical to a semantic approach allows for a better understanding of
how words are related in the context of their meanings. There are situations where the
same word is used but has different meanings. A quarter can mean an American coin,
twenty−five percent, or a football formation. Peng’s research in semantic analysis
suggests gains in accuracy over lexical techniques and offers a high−level approach to
handle documents to help generate better accuracy. These techniques can be used on
doctor notes contained in EHR to help understand the relationship between comments
captured in the notes.
In lexical analysis this information is not utilized, and the frequency of a word is
measured. However, in semantic analysis the meaning of the word is utilized and is
dependent on the context of the words surrounding it as seen in Figure 2.

Figure 2: Example of semantic similarity of words in context. (target orange, context
blue)
To represent a document, a hierarchy of word senses is first constructed. Words are
then mapped to synsets, groupings of words with similar meaning, which are then
labeled with a word that captured the meaning of their relationship. Following this, the
relationships are captured, and documents are then compared to predefined categories
with each synset document representation. Documents with the closest similarities to
the category were then grouped with that particular category [24]. Peng et al mention
that the methods studied were limited by the lexicon utilized. Language is constantly
growing and evolving. If a lexicon is not updated, lexical or semantic approaches may
not be sufficient to cluster future documents as new words and their meanings may not
be captured. This argument is held for any NLP project as most projects rely on current
lexicons.
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2.3

Combining Approaches

For research that utilized NLP, authors mentioned incorporating other biomarkers or
features that were contained in other medical records to build more robust models.
Conversely, in papers that utilized continuous or categorical features, researchers often
mentioned incorporating free form text into their models to increase model
performance. In either case, free form text in EHRs contained in doctor notes could
contain insights related to symptoms associated with Alzheimer’s disease or Dementia,
and biomarkers and other health records may contain attributes characteristic of
Alzheimer’s disease or Dementia. This research aims to improve upon the limitations
mentioned in the previous research by incorporating both free form text from doctor
notes in EHR records or other biomarkers and continuous data a patient may have.

3

Methods

This research makes use of several Machine Learning algorithms which were chosen
due to their widespread acceptance in medical industry and transparency compared to
more complex approaches, such as neural networks. Considering the need for ease of
interpretation by the doctors and medical staff, several models meeting this criterion
were evaluated on EHR medical records. Given the prevalence of Alzheimer’s and
Dementia are low, negative predictive value was deemed the best metric to judge model
performance. Negative predictive value and positive predictive value statistics are
regularly used to describe the performance of diagnostic tests. Negative predictive
value also considers the prevalence of the disease and therefore considers what percent
of the time the test correctly detects no disease. It does so by comparing the total number
of true negative to all negative predictions (true and false). The Negative Predictive
value was used to measure model performance for those individuals who do not have
Alzheimer’s or Dementia
3.1

Logistic Regression

Logistic Regression is a classification algorithm commonly used in current detection
approaches which may be used to solve single or multiple variable classification
problems. Logistic Regression improves upon multiple linear regression (MLR) for
categorical predictors by forcing all predictions to have values between 0 and 1,
mitigating ordinal effects of multiple categories which may occur in a quantitative
algorithm such as MLR [12]. This study will utilize multiple classifications with
Logistic Regression and one-hot encoding, assigning a new feature representing a
condition in the binary states of the condition is present or the condition is not present.
The Logistic Regression models will assign coefficient weights to each feature and its
effect on the outcome probability.
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Figure 3: Example of classification using Logistic Regression.
This paper will utilize models making use of the log−odds ratio as it relates to the
response, which may be interpreted as: adding one unit to X changes the log odds of
the response by β1 or multiplying the odds by eβ1 [25]. This gives us the ability to
interpret models using log odds. Ramsey and Schafer provide a practical example of
interpreting log odds:
For example, it is possible with retrospective samples of lung cancer patients
and of patients with no lung cancer to make a statement such as: The odds of
lung cancer are estimated to increase by a factor of 1.1 for each year that a
person has smoked. This result has tremendous bearing on medical case–
control studies and the field of epidemiology. (p. 609) [25].
Logistic Regression carries assumptions similar to MLR, in that high leverage outliers
can severely impact prediction results, and the assumption is that residuals have equal
mean and variance across the X predictors. These assumptions are checked and can be
validated in the notebooks containing the code for this research paper.
3.2

Random Forest

Random Forest models will be used to benchmark model quality and will act as the
baseline for comparison to other models and applicable research in other papers due to
its ease of implementation and highly explainable nature. The model itself is comprised
of an ensemble of decision trees which can either yield a continuous or categorical
response [29]. These decision trees are often referred to as Classification and
Regression Trees (CART) algorithms [7].
The anatomy of a decision tree consists of a series of decision nodes that split into
branches/edges. Navigation down the decision tree continues through each node and
down the branches until there are no more splits at which case a response, continuous or
categorical, is the final step [28]. The manner in which a decision tree does this is based
on the training features and conditions required for splitting each decision node. As a
result of a technique coined recursive binary splitting, all provided features are
considered and split points are created by finding the lowest cost for all possible splits
[7].
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For classification-based decision trees, a common cost function is the Gini score,
which calculates a measure of the homogeneity of the response classes in each group of
a potential split [7]. In the formula provided below, pk is the proportion of homogeneous
response in a group. An ideal split will produce a pk value of 1 or 0, but a 0.5 for the worst
fit on a binary classification problem [7].
Classification: G = sum(pk * (1 — pk))
Due to the greedy, recursive nature of the algorithm to excessively minimize the cost
function, a large number of splits may be present that could make model interpretation
difficult and result in an overfitted model [7]. Decision trees can have exceptional
performance on training data and are often quite easy to explain, but often underperform in real-life scenarios due to their tendency to overfit the training data. In order
to achieve a more useable model, various adjustments and techniques can be employed
to increase model predictability and robustness.
One such possibility utilized in this research is an ensemble (or collection) of
uncorrelated decision trees, often referred to as a Random Forest (aforementioned). For
classification tasks, the Random Forest will have each decision tree create a prediction
of a response and the response with the most votes is the ensemble output [29]. In
essence, the ensemble model allows for the errors of an individual decision tree to be
reduced or masked by the other trees in the ensemble [29]. By using the “public
opinion” of the collection of the models as a whole, in contrast to that of a specific
model, the ensemble method is much more robust against model overfitting and often
leads to a higher model performance in real world applications [29].

Figure 4: Example of an ensemble of decision trees created by a Random Forest
classifier.
AdaBoost was also utilized and is similar to Random Forest in that it combines
multiple weak learners to generate a strong learner. Weak learners don’t generalize well
to new data because they are overfit or have poor accuracy, but when many weak
learners are combined, they generate a good, generalized representation of the data.
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3.3

Support Vector Machine

Support Vector Machines (SVM) are a type of Machine Learning algorithm that can be
used for both regression and classification. Although it can work in a regression
problem, it is much more commonly employed in classification problems that utilize
the creation of hyperplanes to differentiate between classes. Observations that are
present on either side of the hyperplane are associated with a class.

Figure 5: Example of a classification problem using Support Vector Machine.
The creation of the hyperplane is typically of n-1 dimensions where n is the number
of dimensions present in the data [4]. For example, if a collection of observations with
3 features (excluding response) are trained with the algorithm, the hyperplane that splits
the classes will be 2 dimensional [4]. Due to the infinite nature of a hyperplane, it is
often more practical to describe the hyperplane as a sequence of vectors, often referred
to as support vectors [4]. To improve model performance, the algorithm utilizes a hinge
loss function to maximize the distance between the support vectors that achieves the
greatest separation of classes [4].
In SVM, outputs are normalized to a range of -1 and 1 upon which margins of the
support vectors run [4]. The cost function of the SVM yields a value of 0 if the
prediction and actual values have the same sign, whereas opposite signs yield a
measurable loss value [4]. The cost function will seek to maximize the margin of
separation between each class and subsequently minimize loss [4].
In simpler terms, SVM is designed to maximize the distance between each class
separating hyperplane, and the nearest points to it, also known as the support vectors.
This distance is called the margin, and SVM attempts to draw the optimal line through
the observed data that provides the most margin for all support vectors. This line is not
always 100% linearly separable, so we can incorporate slack variables, which allow for
observations to be on the wrong side of the hyperplane [8]. These slack variables are
used in conjunction with residuals in the cost function to penalize large residuals by a
user defined, constant C amount [15]. This constant C is one of the primary parameters
of SVM that by changing, may result in better classification results as it adjusts the
functional margin between support vectors.
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3.4

Natural Language Processing

Natural Language Processing (NLP) is a process that allows for analysis of text data at
scale and is the use of machine-based methods to process natural language – an example
of this would be the use of NLP on doctor’s notes from EHR. NLP consists of two main
sub-categories of language processing: Natural Language Understanding (NLU) and
Natural Language Generation (NLG) each comprised of subcategories that serve
similar but different purposes, utilize different techniques, and generate different
outputs.
NLU is a process used to create a useful representation of ingested natural language
that is understandable to a machine. This requires the use of artificial languages, such
as python, R, Java, etc. to provide instructions to a machine on how to cluster, classify,
tag, and query text. NLG is the transformation of structured data into human
comprehensible words, phrases, or sentences. Common application of this form of
language processing includes text summarization, labeling of clusters, and question
answering.
Text data was prepared on the lexical level to allow for unsupervised clustering of
EHR features into groups that were most similar to each other. Term frequency (TF)
and term frequency inverse document frequency (TF-IDF) values were used with kmeans clustering, and TF and trigrams with Latent Dirichlet Allocation (LDA) for topic
modeling. The clusters were captured as engineered features for utilization by Random
Forest, Logistic Regression, or SVM model that contains other risk factors and features
associated with a patient record like age, BMI, medical tests taken, and ICD-10 codes
as seen in Table 1.
Table 1: Example of Electronic Health Record schema with NLP-engineered feature.
Patient
Number

Gender

BMI

ICD-10

Physician Comments

12345

F

22

F63.0

67891

M

26

F20

01112

F

25

F03

Patient described risky behavior
when gambling
Patient described memory issues
and difficulty speaking
Patient mentioned forgetfulness

3.5

NLP-Engineered
Feature – At-risk
for Alzheimer’s
0
1
1

Model Training and Hyperparameter Training

Data for modeling was partitioned into a train and test sets, where 70% of the data was
used for training and 30% was used for testing. The national prevalence rate reported
for Alzheimer’s disease is only 10 percent. Since the number of records containing
Alzheimer’s disease or Dementia were infrequent it was important to up-sample these
the training set to improve model performance. This was done using Synthetic Minority
Oversample Technique (SMOTE), where synthetic records containing minority class
attributes are generated. Up-sampling is performed when there is a class imbalance in
the response. This is done because it can be difficult for a model to effectively classify
when there is a class imbalance. If a model is run on data that is imbalanced
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performance metrics typically would underperform. The data set generated by SMOTE
was then used in the grid search cross validation process during the training phase.
To maximize model performance an exhaustive grid search and cross validation was
performed. Parameters for each model were selected and a range of values within each
parameter were assigned to a parameter grid. The up-sampled training data was then
loaded into a 3-fold cross-validation object. During the grid search, all permutations of
the parameters were generated then trained on one portion of a fold and tested on the
remaining portion. This process is repeated until all fold permutations are trained and
tested. Once this process is complete, the grid search is able to identify which
permutation of parameters for a particular model performs best in terms of a user
specified metrics.

4

Data Description

The Electronic Health Records utilized for this research were obtained from the
University of North Texas Health Science Center (UNT HSC) in Fort Worth. The data
is a convenience sample from 3 different clinical settings: Geriatrics, Family Medicine
and Seminary Medicine consisting of EHR for patients 65 years and older. The dataset
spans from January 2016 to December 2019 and contains 4,995 unique patients totaling
46,690 patient visits. There were 3,950 normal patients, 516 Alzheimer’s disease
patients and 889 Dementia (Alzheimer’s disease and others) patients. The total number
of patients that are diagnosed with Alzheimer’s disease or Dementia as a proportion of
the total is at 17.79%. The total proportion of patients with Alzheimer’s disease is
calculated at 10.33%, which closely matches the 10% expected in the general
population.
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Table 2: All tables were relationally linked by Encounter_ID and Person_ID.
Table

Definition

Encounters

Data related to a patient visit where a patient could
have multiple visits.

Vitals

Data related to a patient’s height, weight, BMI, pulse,
etc.

Assessments

Related ICD-10 and doctors' free-from assessment
detailing the visit.

Labs

Data related to a patient’s ordered laboratory tests and
corresponding results.

Medications

Data related to patient’s prescribed drug(s), dose,
current or not current.

CPT_codes

Codes related to patient’s tests, surgeries, evaluations
for billing and the patient’s free-from reason for visit.

ICD-10

Codes related to patient’s diagnosis recorded as codes.

4.1

Data Preparation

To adequately utilize all the data available, the tables containing the EHR data outlined
in Table 2 were joined using the unique encounter id that linked all the tables together
in a relational manner. There was a one-to-many relationship between the unique
patient id and the encounter id, meaning that it is possible for multiple iterations of a
single patient’s information to be present in the dataset. The central table onto which
we planned to join all of the other tables was the “Encounters” table, which houses all
patients and visit metadata. Some fields from this table were gender, age, reason for
visit, and more. After dropping columns that lack diagnostic properties (insurance
provider, location, etc.), from the encounters table we then moved onto merging the
other tables using the unique encounter id as the main key.
The vitals table is comprised of commonly taken information from when the patients
entered the facility such as temperature, weight, height, body mass index, and blood
pressure. It was possible for patients to have multiple vital measurements taken within
a single visit. When multiple measurements occurred, we took the median of the
continuous vital measurements to “flatten” the vitals to a one-one relationship between
the unique encounter and the vital information. After this process was completed, the
vitals table was joined onto the encounters table.
The assessments table contains the doctor’s “free form” notes about the patient. This
table is a unique perspective that the study offers because the opportunity to leverage
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the text data can allow for relationships that humans understand, but previous research
has not used because much of its content is not necessarily measurable and tends to be
more subjective in nature. In order for Machine Learning models to ingest unstructured
text data, the “bag of words” must be transformed into a matrix of continuous features.
To achieve this, all words were stemmed and converted to lowercase. Following, “stop
words”, words that do not add to the context of a physician note such as: “a”, “and”,
“the”, “he”,” she” and other articles and pronouns were removed. Next, the remaining
nouns and verbs after stop word removal were then put into a Term Frequency – Inverse
Document Frequency (TF-IDF) which created a dense matrix of continuous
representations for each unique word remaining in the corpus. Due to the excessive size
of this table, the dense matrix was used to create engineered features by utilization of
k-means clustering. The clusters created logical, separate bins to group various text
fields to a higher-level summary in a much more dynamic way. Once the clusters were
created, each text derived feature was one-hot encoded to generate a sparse, yet reduced
representation of the original matrix. The resultant structure was joined back onto the
original encounters table for use in modeling.
In addition to k-means clustering, Latent Derelict Allocation topic modeling for
physician notes in the assessments table was also performed. Data was cleaned using
the same aforementioned process as the k-means clustering. Tokens were then formed
into trigrams, or, three-word chunks, to identify the most common three-word topics.
The trigrams were then loaded into a Term Frequency (TF) matrix. Once the topics
were generated, each record in the assessments table was labeled with its corresponding
topic, then encoded, and joined to the encounters table using the unique encounter ID.
The labs table contains patient lab information, according to the tests ordered by the
patient’s physician. The lab information constitutes a variety of features that required
different forms of feature engineering to tidy data in a format that would work well
with a Machine Learning model. When concentration ranges were given, the median of
that range was used; if a maximum or minimum range was given, the high or low cutscore was used. Besides continuous lab results, some labs contain information of a more
categorical nature. Among these are results of “normal” or “abnormal”. Utilizing these
specific labs required one-hot encoding of the potential values available for that lab.
The continuous types of lab result were found to have much less feature importance
than the abnormal lab work ind. Many of the labs with a categorical response were
observed to have non-significant feature importance and were not utilized in the final
dataset. After reduction all labs were joined onto the encounters table.
The medication table is comprised of the entire medication history for each unique
patient. In order to ensure data leaks are not present, medications needed to be filtered
using the dates provided in both the medication table and the encounters table. This
ensured that only current medications up until the encounter were used in the final table.
Once the “current” medications for that individual patient and encounter were subset,
the output was joined onto the encounters table using encounter id.
The CPT codes table is comprised of various procedures performed during the
patients’ visit for billing purposes. It was suggested that use of the procedures in the
dataset may help determine if other ailments could be used for screening purposes.
Several diseases (diabetes, hypertension, depression) are known comorbidities and
occur more frequently for individuals with neurocognitive disease. The CPT
description was joined back onto the encounters table using the encounter id.
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The ICD-10 table is comprised of documented diagnoses for a patient. In all, there
were 4,753 unique ICD-10 codes with the data set. This caused excessive addition of
features when one-hot encoding. To reduce feature space, we used lower granularity
representation of the ICD-10 code by mapping to a Clinical Classifications Software
Refined (CCSR) code which reduced the dimensionality of ICD codes from 4,753 to
just 415 unique codes [26]. To prevent target leakage, records containing the NVS011
CCSR code, a group of 25 ICD-10 codes specific to neurodegenerative diseases, were
removed. Once the feature reduction was complete, the ICD-10 table was joined back
onto the encounters table.
4.2

Exploratory Data Analysis

Exploratory Data Analysis (EDA) has identified trends showing strong correlation in
several features. Age is the number one factor, and greatly increases the likelihood of
dementia. The median age for those diagnosed with neurocognitive disorders is almost
10 years older than those without the diagnosis.

Figure 6: Correlation matrix of Age, Weight, BMI, height, pulse, and neurocognitive
disorder.
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Figure 7: Correlation matrix of systolic and diastolic blood pressure, assessment topic
8, temperature (F), diagnosis of nervous system signs and symptoms, and
neurocognitive disorders.

Figure 8: Correlation matrix of respiration rate, assessment group 13, diagnosis of
depression, reason for visit group 2, and neurocognitive disorder.
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Figure 9: Visualization of age distribution for Alzheimer’s disease and Dementia
patients.

Figure 9: Visualization of median age differences between patients with/without
Alzheimer’s disease and Dementia patients.

Figure 10: Visualization of median weight distribution for Alzheimer’s disease and
Dementia patients.
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Figure 11: Visualization of weight vs age by gender for each patient type
The median age for those diagnosed with neurocognitive disorders is almost 10 years
older than those without the diagnosis.
Research also shows that Alzheimer’s disease and Dementia patients are typically
underweight compared to their healthy peers. Figures 10-12 display compelling
evidence that weight could be a factor in predicting neurocognitive disorders.
Alzheimer’s disease and Dementia patients have a higher percentage of depression
than healthy peers in the sample population. Figure 14 exemplifies our finding support
research by Johnson et al [13].
Features identified from EDA turned out to be influential within each Machine
Learning algorithm. Random Forest and Logistic Regression reported weights strongly
associated with each of these features as shown in the results section.
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Figure 12: Visualization of weight distribution for Alzheimer’s disease and Dementia
patients.

Figure 13: Visualization of age distribution for Alzheimer’s disease and Dementia
patients.
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Figure 14: Visualization of the effect of depression on each patient type. The features
identified in this EDA turned out to be influential features within each Machine
Learning algorithm. Random Forest and Logistic Regression reported weights
strongly associated with each of these features as shown in the results section.

5

Results

To build the initial model encompassing all years, the entire dataset was used in a 3fold cross validation using stratified splits to maintain target ratios. Initial model
building started with a stepwise selection approach using all 1,296 predictors available
in the data set. All features were investigated and scrubbed of any information that
could leak the response variable Alzheimer’s disease or Dementia such as NVS011
CSSR codes and text fields that had direct indication or mention of the disease. Text
features were reviewed for response variable before and after NLP processing. After
obtaining coefficients for all features, feature reduction was applied, narrowing down
coefficients to a smaller subset of 150 of the features with highest correlation to reduce
overfitting and model complexity.
Multiple sets of data were created from patient encounters by grouping patients into
their first year, second year, third year, fourth year and beyond visits, and all encounter
occurrences. The intent of sub-setting by annual visit number allows for clinicians to
stratify patients into the most logical bin for rule out of Alzheimer’s disease or
Dementia. Additionally, inclusion of an all-data superset allows for model comparison
against yearly data. Each year’s subset was then split into a 70/30 set in which the
training set was up-sampled to improve model performance by ensuring the model is
not biased towards the most common occurrence (individuals without Alzheimer’s
disease or Dementia). Each model for each training set was fitted using cross validation,
and features were manually reduced using highly correlated medication and CPT code
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data resulting in 661 total features. The best model fit resulting from the cross validation
was then measured using the hold out set.
After performing an exhaustive grid search on Logistic Regression, Random Forest,
and SVM, the best models for their respective subset are listed in Table 3.
Table 3: Best model type by year and best model for all data.
SUBSET

YEAR 1

YEAR 2

YEAR 3

YEAR
4+

ALL
DATA

MODEL

Random
Forest

Random
Forest

Random
Forest

SVM

AdaBoost

NPV

0.9798

0.9741

0.9891

0.9635

0.9886

ACCURACY

0.8424

0.8352

0.8710

0.8754

0.9081

SPECIFICITY

0.8511

0.8480

0.8759

0.8997

0.9167

SENSITIVITY

0.2060

0.1948

0.1828

0.3071

0.1235

AUC

0.5929

0.5845

0.5860

0.6352

0.5560

The best performing model was AdaBoost on all data. It returned the highest
negative predictive value, accuracy, and specificity for all models and all years. The
next highest performing model was the year 3 Random Forest model, followed by the
year 1 Random Forest model. All models in Table 3 show strong negative predictive
value, accuracy, and specificity but are not as strong in sensitivity or AUC metrics.
Negative predictive values and specificity are metrics that identify a model’s ability
to correctly detect negative values. Negative predictive value (NPV) is a ratio between
true negatives and true negatives plus false negatives, while specificity is a ratio of true
negatives over true negatives plus false positives. Since the test set is representative of
the whole dataset, many of the records are negative for Alzheimer’s disease or
Dementia. The models for each year show an exceptional ability to detect true negatives
in the data.
Sensitivity is the ability for a model to detect true positives for all classified positive
cases. All models performed poorly in this area as the scores were not able to surpass
0.2060. The sensitivity scores were low due to preferential fitting towards the highest
NPV possible in order to reduce unnecessary testing.
Correctly framing the “context of use” for the rule out screening is critical for
determining success. Models investigated here have an exceptional ability to screen
patients and identify those who does not have Alzheimer’s disease or Dementia with
an NPV between 97.78 and 96.35% over a 4-year time span. The median number of
doctor visits for all patients during this time span was 6-7 visits; indicating the rule out
screen would likely have been able to screen all patients 65 years and older, who saw
their doctor.
Sensitivity and specificity metrics are usually associated with gold standard tests
(CSF and PET). Performance characteristics for rule out screening, such as NPV and
PPV, are used to determine how well predictions were made considering prevalence.
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The rule out screening demonstrated very accurate detection rate of 75% for individuals
that truly do not have disease (NPV ≈ 98.86% overall). Unfortunately, after accounting
for the prevalence rate, the rule out screen has a high false positive rate and does not
reliably identify Dementia and Alzheimer’s disease in the overall population. Rule out
screening only correctly identified ≈ 15% of patients with Dementia and Alzheimer’s
disease (PPV ≈ 18 %). Future comparison of rule out screening to gold standards tests
would help to support findings from this study.
Natural Language Processing generated several clusters that ranked high in Random
Forest feature importance. Out of nearly 1,200 features, 13 NLP-engineered features
were in the top 50, and 3 were in the top 15. The use of NLP features with traditional
Machine Learning techniques has been infrequently mentioned in previous research
and shows promising results as they contribute to models in a significant manner.
Accuracy scores for all models had values ranging from 0.8352 to 0.9081. Accuracy
is a ratio of true positives and true negatives over the total samples. Since negative
values account for over 85% of the data much of the accuracy score is due to each
model’s strong ability to detect negative cases. However, each model’s poor
performance in detecting positive cases prevents the accuracy score from being stronger
and closer to the model NPV.
AUC also performed poorly for all models as AUC scores depend on a balance of
specificity and sensitivity scores. Due to each model’s poor performance in sensitivity,
the resulting AUC scores are also low.
Table 4: Random Forest Feature Importance for All Data Model – Top 15 Features.

Features
Gini Importance
0.09897
enc_AgeAtEnc
0.05520
vit_weight_lb
0.04997
vit_BMI_calc
0.03457
vit_height_cm
0.03366
vit_pulse_rate
0.03214
vit_bp_systolic
0.03214
vit_bp_diastolic
0.02968
asmt_topic_8
0.02867
vit_temp_deg_F
0.02048
ccsr_Nervous system signs & symptoms
0.01946
vit_respiration_rate
0.01274
visit_number
0.01043
asmt_kmeans_13
0.00927
ccsr_Depressive disorders
0.00866
rfv_cluster_2
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Random Forest can also be used to determine features that contribute most to model,
or feature importance, using Gini Importance measures in which more important
features have larger values and less important values have smaller values. Gini
importance is calculated by adding decreases in node impurity and averaging the
differences for all trees. Using these values, the top n features can be subset and used
to trim insignificant features from the model in order to avoid overfitting. Feature
importance for both future modeling and model understanding was derived by fitting
the best performing Random Forest model on the whole data set. Once the model was
fit, the feature importance attribute was applied to the Random Forest object, where a
data frame was generated and sorted.
The NLP features took 11 out of the top 25 most important features using Recursive
Feature Elimination with the Random Forest algorithm, indicating the data within
doctors’ assessments is useful in detecting the disease. Several noticeable features
identified as significant by Random Forest feature importance were NLP-engineered
features: asmt_topic_8, asmt_kmeans_13, and rfv_cluster_2. Physician notes were used
to generate asmt_topic_8 and asmt_kmeans_13 and patient’s reported reason for visit
was used for topic rfv_cluster_2. The NLP features were named based upon the table
they originated from and the topic or k-means cluster they were placed in, respectively.

Figure 15: Visualization of word frequency within asmt_kmeans_13 cluster Larger
text indicates more frequency.
Rfv_cluster_2 included primarily follow-up appointment visits, consisting of
numeric week follow-up frequencies, physical therapy appointments, and prescription
refill timelines among other reasons. The top NLP-engineered feature, asmi_topic_8,
was generated utilizing Latent Derelict Allocation topic modeling.
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Table 5: asmt_topic_8 – LDA derived tri-gram phrases provide insight on the contents
of this topic.
Feature

asmt_topic_8

Tri-gram Phrases
10_mg_daily,
metformin_1000_mg,
type_2_diabetes,
2_diabetes_mellitus,
encounter_medication_review,
low_blood_sugar,
per_ada_guidelines,
medication_review_counseling,
mg_daily_continue,
essential_primary_hypertension

The topics provided by this cluster, along with the asmt_kmeans_13 cluster, show
trigrams that are strongly associated with Alzheimer’s disease and Dementia as comorbidities. The direct mention of diabetes mellitus, diabetes, low blood sugar, or drugs
like metformin used to treat diabetes were important in generating the NLP feature.
Additionally, hypertension was mentioned in this cluster demonstrating a strong
association between the contents of this cluster, and Alzheimer’s disease and Dementia.

6

Ethics

Three ethical areas were identified and were required to be maintained throughout the
course of study.
The first ethical standard was regulation of data storage and controlled access to
Patient Health Information (PHI). Access to the EHR records required approval from
the UNT HSC IRB - Project Title#: 1660705-1, Reference#: 2020-11 and compliance
to the Healthcare Insurance Portability and Accountability Act (HIPAA) required all
EHR records were scrubbed of PHI and anonymized to prevent identification of
patients. User access was provided by UNT HSC IT (Information and Technology)
security, VPNs and unique login credentials to a private server were issued. The secure
private server ensured ethical handling and storage of the data and provided an ideal
location for cleaning, manipulating, modeling, and visualizing data and results within
the UNT HSC domain.
The second ethical standard was related to the Machine Learning process. The use
of powerful computers and large data sets combined with algorithms can solve complex
problems not directly visible to humans. This research has shown promise in utilizing
opportunities previously untapped. The ethical conflicts that arise from Machine
Learning algorithms are lack of transparency, reproducibility, ethics, and effectiveness.
The article “Machine Learning and artificial intelligence research for patient benefit:
20 critical questions on transparency, replicability, ethics, and effectiveness” was used
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as framework of questions that were directly investigated during the creation of the
Alzheimer’s disease and Dementia rule out screening [19]. Throughout this study the
following 6 topics were repeatedly considered and evaluated: Inception, Study,
Statistical methods, Reproducibility, Impact evaluation, Implementation.
The third ethical standard was related to the current lack of predictive screening
creating a situation where patients go unscreened or diagnosed until it is too late. The
Alzheimer’s disease and Dementia rule out screen reports metrics showing real benefit
could be provided to patients 65 and older when implemented. Ethically, it is in the best
interest of public health to continue this research further defining limitations and
implications. Some statistical concerns surrounding low PPV, false negatives and false
positives are present. Test results need to be clearly explained to patients and doctors,
so the correct interpretations are easily understood. The rule out screen only indicates
no disease is present. Ethically, the interpretation of the Alzheimer’s disease and
Dementia rule out screen can be simply stated as: the rule out screen can only detect
absence of disease; for all other findings, patients are recommended to seek additional
medical care and possible escalation to CSF or PET screening.

7

Discussion

Rule out screening quickly provides patients with information about their
neurocognitive health. This is vastly different than current assessment practices where
no predictive information is available. This new paradigm allows for patients to act
based on information provided from the rule out screen.
Gold standard screening methods historically fall short when a patient or family
member has memory concerns. If they are interested in diagnosis/treatment, there few
alternatives. Screening currently consists of non-predictive options and typically costs
between one thousand and several thousand dollars. Traditional screening methods also
suffer from a national shortage of Neuropsychologists, which may introduce several
months delay to neurological assessments. The shortcomings of gold standard
screenings are further exemplified when more than half of patients go undiagnosed.
Rule out screening can be done every visit reliably, letting patients know they do not
have any disease with very high certainty. Conversely, rule out screening cannot
accurately confirm patients are truly positive for the disease. The test only provides
patients that do not screen negative with the strong recommendation to consult a doctor
for additional, higher-level testing. Multi-tiered approaches have successfully been
used; most recently in 2020 rapid IgM/IgG testing to assess Coronavirus disease in
emergency rooms 1-2 days before gold standard screening [30]. Breast cancer detection
highlights the role of mammography for early-stage detection and then relies on
biomarker and MRI when cases are escalated [31].
This research has extended previous Machine Learning approaches that aim to
facilitate detection and screening of Alzheimer’s disease and Dementia by utilizing
NLP applied to doctors’ notes. There is substantial evidence that NLP has positively
improved the prediction performance in screening for Alzheimer’s disease and
Dementia. Identifying phrases that contribute towards feature importance score can be
accomplished using term frequencies and word clouds. Several key phrases associated
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with Alzheimer’s disease and Dementia like hypertension, depressive, depression, and
disturbance are known co-morbidities.
In addition to the NLP features, several previously discovered correlated features
such as: age, blood pressure, under-weight, and blood sugar levels were further
validated as significant in this research. Utilizing more complex algorithms in the NLP
space will likely yield marginally better performance, and evidence suggests that future
work may benefit from a deeper application of these techniques and the use of a medical
specific lexicon.
Despite NLP-engineered features contributing towards a large portion of model
predictive ability improvements for detections of positive cases is needed to address
poorly performing positive predictive power, sensitivity, and AUC. This suggests that
more future engineering specific to positive cases needs to be done, or incorporation of
more features used to help diagnose Alzheimer’s disease or Dementia like blood
biomarkers, or cognitive tests should be included in future work.
Other improvements can be made to data storage and models by migrating data to a
graph data base. Data for this research was relational in nature and during processing
data required aggregation of fields to flatten data to an encounter basis. In doing so a
record was able to provide information on whether a feature occurred but was no longer
able to provide information about the order in which features occurred within an
encounter. Utilizing a graph database allows for these relationships to be preserved in
a form that can be utilized by models and could be advantageous in future iterations of
this work. Additional studies should be done that independently rule out Dementia and
Alzheimer’s disease separately. Stratification by disease, generation of new features
space and creation of new models which are better tuned to each disease should produce
improved performance metrics.
Any person over 65 or with a family with elderly members needs to consider the
current state of healthcare: the lack of predictive tests, overly expensive gold standard
testing that sadly ends with a terminal disease which has been historically
underdiagnosed for years. Considering the previous statement, it only makes sense that
rule out screening for undiagnosed Alzheimer’s disease and Dementia using an EHR
based machine learning be considered as the first line of defense in the fight against
these diseases. Ethically, the test does not put patients at-risk because a diagnosis is not
given. Only the absence of disease is determined, therefore patients with a non-negative
result would need to seek additional care for effective diagnosis.

8

Conclusion

The social and economic impact of Alzheimer’s disease and Dementia are incredible
compared to heart disease or even cancer. Considering only limited treatment options
are available for neurodegenerative disease being able to effectively use health care
records as an early rule out tool has significant implications as well as cost-savings.
Rule out screening described within this study uses health care systems already in place
that more efficiently guide patient care and treatment.
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Rule out screen has the potential to save billions of dollars for patients, healthcare,
and insurance companies. In 2020, the Alzheimer’s Association reported staggering
numbers for payments made by Medicare and Medicaid combined with other payments
total nearly 300 billion dollars for the 5.8 million people age 65 and older living with
Alzheimer’s disease and Dementia. The rule out screen as it is currently configured
today could provide significant improvement to families and patients by providing
knowledge where none has existed. If a gold standard testing available today screened
everyone age 65 and older tomorrow, there would be millions of patients that would
need to be screened. In 2020, 16.9 percent of the U.S. population were 65 and older;
that equates to 55.9 million seniors. Screening this entire elderly population would
cost somewhere between 55 to 385 billion dollars depending which gold standard test
was used. If the Alzheimer’s disease and Dementia rule out screening was used as the
first line screening tool the number of gold standards tests could be reduced 75 percent.
The estimate savings would be 41.2 to 288.8 billion dollars compared to only using
gold standard screenings. The rule out screening described with this study will
considerably reduce screening costs, increase accessibility, improve healthcare options
for our elderly population. It is important to acknowledge that the findings of this
research have shown great potential for use of NLP in detection of Alzheimer’s disease;
however, more research should be performed until conclusive decisions can be made
as to whether an individual has Alzheimer’s disease.
Acknowledgments. Jacquelyn Cheun, Ph.D.1, and Faizan Javed, Ph.D.1, – Capstone
Professor
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